GAMMA Investing’s Immunome IMNM Stock Holding History

GAMMA Investing’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.6K	Buy	1,680 +90	+6%	+$1.93K	﹤0.01%	2529
2026 Q1	$34.8K	Buy	1,590 +211	+15%	+$4.7K	﹤0.01%	2424
2025 Q4	$29.6K	Buy	1,379 +441	+47%	+$7.74K	﹤0.01%	2397
2025 Q3	$11K	Buy	938 +7	+0.8%	+$70	﹤0.01%	2835
2025 Q2	$8.66K	Buy	931 +19	+2%	+$156	﹤0.01%	2875
2025 Q1	$6.14K	Buy	912 +702	+334%	+$6.74K	﹤0.01%	2995
2024 Q4	$2.23K	Buy	210 +81	+63%	+$979	﹤0.01%	3191
2024 Q3	$1.89K	Buy	+129	New	+$1.83K	﹤0.01%	3089

Other funds holding IMNM

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return

MFG

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing's IMNM Position: Q2 2026 in Review

GAMMA Investing increased its Immunome (IMNM) stake by 5.7% in Q2 2026, buying an estimated $1.93K and bringing the position to 1,680 shares worth $35.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2529.

GAMMA Investing first reported a position in IMNM in Q3 2024 and has held it in 8 quarters since. 7 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

GAMMA Investing held 1,680 shares of Immunome worth $35.6K as of Q2 2026.
GAMMA Investing bought 90 Immunome shares in Q2 2026, an estimated $1.93K.
Immunome made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2529 holding.
GAMMA Investing first reported a position in Immunome in Q3 2024 and has held it in 8 quarters since.
7 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.